Bestimmung von Repolarisationswellen unter Verwendung eines Simulierten Herzmodells

EP4817522 7. Oktober 2026

Anmelder: Biosense Webster (Israel) Ltd. 🇮🇱

Details

Veröffentlichungs-Nr.
EP4817522
Anmeldetag
1. April 2026
Veröffentlichung
7. Oktober 2026
Rechtsraum
EP
Offizieller Volltext

Abstract

An example method may use simulated data a virtual heart model to measure characteristics including cell potential and determine repolarization timing, while collecting accurate, simulated intracardiac signals. The determined characteristics (e.g., repolarization timing) may be annotated for reference. The collected signals combined with the annotated timing may be used to train an AI model. The AI model may be configured to determine characteristics such as repolarization timing based on input of one or more intracardiac signal(s). The AI model may be tested by inputting a dataset comprising intracardiac signals from other heart models and receiving a predicted ARP from the AI model. The predicted ARP may be compared with known ARPs to determine an accuracy of the AI model. The other heart models may be associated with heart conditions and/or complications, such as tachycardias.

Anmelder

Firma
Biosense Webster (Israel) Ltd.
Land
🇮🇱 Israel
🇮🇱 Biosense Webster (Israel)

Israelische Gesellschaft eines Medizintechnikunternehmens, die Kathetersysteme und Geräte für die kardiologische Diagnostik und Behandlung von Herzrhythmusstörungen entwickelt.

1.808 Patente in unserer Datenbank

Noch Fragen?

Wir helfen Ihnen gerne weiter. Schreiben Sie uns einfach.

Kontakt aufnehmen